HyTest Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 112

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

HyTest General Information

Description

Manufacturer of immunological reagents intended for the in vitro diagnostic and research sectors. The company offers monoclonal antibodies, polyclonal antibodies, purified antigens, cardiac markers, infectious disease reagents, inflammation markers, metabolic syndrome reagents, autoimmune disease reagents, veterinary diagnostic reagents, and molecular biology products, enabling its clients to develop accurate assays through high-quality antibodies and antigens.

Contact Information

Website
www.hytest.fi
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • Intelligate 1, 6th floor
  • Joukahaisenkatu 6
  • 20520 Turku
  • Finland
+358 02
Primary Industry
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Intelligate 1, 6th floor
  • Joukahaisenkatu 6
  • 20520 Turku
  • Finland
+358 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HyTest Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HyTest‘s full profile, request access.

Request a free trial

HyTest Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of immunological reagents intended for the in vitro diagnostic and research sectors. The company offers mon
Biotechnology
Turku, Finland
112 As of 2018

San Diego, CA
 

Farmington, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HyTest Competitors (28)

One of HyTest’s 28 competitors is Aviva Systems Biology, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aviva Systems Biology Formerly VC-backed San Diego, CA
CaroGen Venture Capital-Backed Farmington, CT
Novus Biologicals Formerly PE-Backed Centennial, CO
GeneTex Formerly VC-backed Irvine, CA
Pacific Immunology Corporation Ramona, CA
You’re viewing 5 of 28 competitors. Get the full list »

HyTest Patents

HyTest Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4752159-A1 Antibody against estradiol immunocomplex and kit thereof Pending 29-Nov-2024
JP-2026077630-A Anti-human immunodeficiency virus type 1 p24 and type 2 p26 antibodies and uses thereof Pending 25-Oct-2024
EP-4733318-A2 Antibody against human immunodeficiency virus type 1 p24 and type 2 p26 and uses thereof Pending 25-Oct-2024
EP-4733318-A3 Antibody against human immunodeficiency virus type 1 p24 and type 2 p26 and uses thereof Pending 25-Oct-2024
US-20260118359-A1 Antibody against human immunodeficiency virus type 1 p24 and type 2 p26 and uses thereof Pending 25-Oct-2024 C07K16/468
To view HyTest’s complete patent history, request access »

HyTest Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HyTest Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore HyTest‘s full profile, request access.

Request a free trial

HyTest FAQs

  • When was HyTest founded?

    HyTest was founded in 1994.

  • Where is HyTest headquartered?

    HyTest is headquartered in Turku, Finland.

  • What is the size of HyTest?

    HyTest has 112 total employees.

  • What industry is HyTest in?

    HyTest’s primary industry is Biotechnology.

  • Is HyTest a private or public company?

    HyTest is a Private company.

  • What is the current valuation of HyTest?

    The current valuation of HyTest is .

  • What is HyTest’s current revenue?

    The current revenue for HyTest is .

  • Who are HyTest’s investors?

    EQT Credit, HarbourVest Partners, and Summa Equity have invested in HyTest.

  • Who are HyTest’s competitors?

    Aviva Systems Biology, CaroGen, Novus Biologicals, GeneTex, and Pacific Immunology are some of the 28 competitors of HyTest.

  • When was HyTest acquired?

    HyTest was acquired on 23-Sep-2021.

  • Who acquired HyTest?

    HyTest was acquired by Mindray.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process